0001209191-12-008690.txt : 20120209 0001209191-12-008690.hdr.sgml : 20120209 20120209161014 ACCESSION NUMBER: 0001209191-12-008690 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120208 FILED AS OF DATE: 20120209 DATE AS OF CHANGE: 20120209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH IAN F CENTRAL INDEX KEY: 0001197032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 12587282 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2012-02-08 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197032 SMITH IAN F C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139 0 1 0 0 EVP & CFO Common Stock 2012-02-08 4 S 0 9667 36.80 D 24168 D Common Stock 4908 I 401(k) Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $36.80 (range $36.48 to $37.20). Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. David T. Howton, Attorney-In-Fact 2012-02-09